http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2397401-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4245 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4245 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 |
| filingDate | 2006-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9a7fd2923c9bdbac3f262bd97957c0e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d361c8cd448909c6953bdb08cd51e78 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_801d43c0796895b791a449c44cb4a228 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d765946d0f18275765aa09d565a13c4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd53ce2c4146d033830f604a531158d1 |
| publicationDate | 2013-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2397401-T3 |
| titleOfInvention | Aryl isoxazol-4-yl-oxadiazole derivatives |
| abstract | Isoxazol-4-yl-oxadiazole derivatives of the formula in which R1 is hydrogen, halogen, aryl, heterocyclyl, heteroaryl, cyano, C1-7 alkyl, - (CH2) n-cycloalkyl, - (CH2) nN (R) 2, - (CH2) nO-C1-7 alkyl or - (CH2) n-OH; n is the number 0, 1 or 2; R is hydrogen or C1-7 alkyl; R2 is cycloalkyl, aryl, a heteroaryl selected from the group of quinolinyl, indolyl, pyridinyl, triazolyl, benzotriazolyl, isoxazolyl, thiophenyl, benzoimidazolyl, dihydrobenzimidazolyl-2-one, imidazolyl, oxazolyl, oxadiazolyl and optionally substituted heterocyclyl, one or more substituents, selected from the group formed by halogen, cyano, nitro, C1-7 alkyl, C1-7 alkoxy, C1-7 alkoxy substituted by halogen, C1-7 alkyl substituted by halogen, C (O) O-C1-alkyl 7, C1-7 alkylsulfonyl, -NRaRb, -C (O) -NRaRb, -C (O) -heterocyclyl, benzyloxy, heterocyclyl optionally substituted by hydroxy, halogen or C1-7 alkyl, or is heteroaryl optionally substituted by C1-7 alkyl ; Ra and Rb are independently hydrogen, C1-7 alkylsulfonyl, -C (O) H, - (CH2) nN (R) 2, - (CH2) nO-C1-7 alkyl, - (CH2) nS-C1-alkyl 7, - (CH2) nS (O) 2-C1-7 alkyl, heteroarylsulfonyl, C1-7 alkyl, - (CH2) n-heterocyclyl optionally substituted by C1-7 alkyl, or is - (CH2) n-cycloalkyl, - ( CH2) n-heteroaryl, - (CH2) n-OH, - (CO) -R ', wherein R' C1-7alkyl, cycloalkyl or heteroaryl; R3 is aryl or heteroaryl, which are optionally substituted by halogen or C1-7 alkyl substituted by halogen; and pharmaceutically acceptable acid addition salts thereof. |
| priorityDate | 2005-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 602.